FOR IMMEDIATE RELEASE
MESA, Ariz. — January 29, 2026
We are excited to announce our latest publication is now available online ahead of print in the American Journal of Perinatology! “Comparative Risk of Neonatal Ischemic Encephalopathy in Operative Vaginal Delivery Versus Cesarean Section at Complete Dilation: A Systematic Review and Meta-Analysis.” is now available online at this link: https://www.thieme-connect.de/products/ejournals/abstract/10.1055/a-2796-1349 This systematic review and meta-analysis examines critical neonatal outcomes in second-stage delivery decisions, comparing the risk of neonatal hypoxic-ischemic encephalopathy (HIE) between operative vaginal delivery (including forceps and vacuum subtypes) and cesarean section performed at complete cervical dilation. Key insights include elevated HIE risk with operative vaginal delivery compared to spontaneous vaginal delivery, but comparable overall risk to cesarean at complete dilation—with subgroup findings suggesting forceps-assisted delivery may carry lower risk in certain scenarios. This work underscores the importance of weighing risks and benefits in intrapartum management to optimize neonatal safety. Full text available via the journal (DOI link above). Congratulations to the research team on this important contribution to obstetric evidence!
About Dr. Greg Marchand
Greg J. Marchand, MD, FACS, FACOG, FICS, is a dual board-certified obstetrician-gynecologist and minimally invasive gynecologic surgeon practising in Mesa, Arizona. He holds the ABOG Focused Practice Designation in Minimally Invasive Gynecologic Surgery and directs the Marchand Institute for Minimally Invasive Surgery, a 501(c)(3) tax-exempt non-profit research and educational corporation (EIN 42-2857240). He is Program Director of an SLS-accredited fellowship in Minimally Invasive and Robotic Gynecologic Surgery, holds three issued United States patents, and has served as Principal Investigator on eight FDA clinical trials. His systematic reviews are prospectively registered with PROSPERO, reported to PRISMA standards and appraised with the Cochrane Risk of Bias 2 tool. He accepts no industry funding for his research.
Media Contact
Maria A. Sainz
Director of Communications and Media Relations
maria@marchandobgyn.com
(480) 999-0905
Newsroom and press kit · Full publication list · Research methodology · Expert commentary topics
###







